- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hyperlipoproteinemia Type II in Russian Federation
Total 1152 results
-
AB ScienceCompletedOvarian CancerFrance, United Kingdom, Ukraine, Algeria, Russian Federation, Spain
-
AbbVieCompletedAcute Myeloid Leukemia (AML)Russian Federation
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Russian Federation, Israel, Croatia, Czech Republic, Slovenia
-
University of JenaRecruitingChronic Myeloid Leukemia in Myeloid Blast CrisisGermany, Czechia, Russian Federation, Ukraine
-
CytokineticsCompletedNon-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States, Russian Federation
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, South Africa, Russian Federation, Former Serbia and Montenegro, North Macedonia
-
Genentech, Inc.CompletedMetastatic Melanoma, BRAF V600 Mutation PositiveKorea, Republic of, Russian Federation, Israel, United States
-
Affimed GmbHTerminatedLeukemia, B-CellAustria, Israel, Russian Federation, Poland, Czechia
-
Benitec BioPharma LtdCompletedHead and Neck Squamous Cell CarcinomaAustralia, Russian Federation
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II;Pompe's DiseaseCzechia, Taiwan, Belgium, Germany, Korea, Republic of, United States, Argentina, Australia, Austria, Brazil, Canada, Denmark, France, Hungary, Italy, Japan, Mexico, Netherlands, Poland, Portugal, Russian Federation, Spain, Switzerland, Turk... and more
-
NovartisCompletedType 2 Diabetes MellitusRussian Federation, Germany, United States
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell CarcinomaChina, Argentina, Brazil, Russian Federation, Bulgaria, United States
-
AB ScienceTerminatedMetastatic MelanomaFrance, Spain, Italy, United States, Czechia, Germany, Russian Federation
-
Janssen Research & Development, LLCCompletedMultiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Plasma Cell NeoplasmUnited States, Belgium, Russian Federation
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type II | Diabetes Mellitus, Non Insulin DependentUnited States, Poland, Bulgaria, India, Malaysia, Romania, Canada, Russian Federation, Argentina, Puerto Rico, Czech Republic, United Kingdom, Mexico
-
Kidney Cancer Research BureauCompletedCarcinoma, Renal Cell | Clear Cell Renal Cell CarcinomaRussian Federation
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Spain, China, India, Russian Federation, Turkey, Germany, Japan, United Kingdom, France, United States
-
Novartis PharmaceuticalsCompletedType II Diabetes Mellitus | Congestive Heart FailureRussian Federation, Singapore, Italy, Czechia, Lithuania, Germany, Guatemala, India, Denmark, Estonia, Slovakia, Romania, Latvia, Greece, Poland
-
Hoffmann-La RocheCompletedRenal Cell Carcinoma | Chronic Myelogenous Leukemia | Malignant MelanomaCanada, India, Bulgaria, Russian Federation, Spain, South Africa, Slovakia
-
PfizerCompletedHyperlipidemiaUnited States, Spain, Taiwan, United Kingdom, Canada, Mexico, France, Hungary, Lithuania, Colombia, Romania, Russian Federation
-
AstraZenecaBristol-Myers SquibbCompleted
-
AstraZenecaRecruitingUnresectable /Inoperable Locally Advanced (Stage II-III) Non-small Cells Lung Cancer (NSCLC)Russian Federation
-
AmgenCompletedDiabetes, Hyperlipidemia, Mixed DyslipidemiaUnited States, Canada, France, Korea, Republic of, China, Argentina, Russian Federation, Colombia, Turkey, Brazil
-
Mologen AGCompletedAdvanced Colorectal CarcinomaUnited Kingdom, Germany, Austria, Czech Republic, France, Russian Federation
-
Eli Lilly and CompanyCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerItaly, United States, Russian Federation
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsRussian Federation, Korea, Republic of, Israel, South Africa, Belarus
-
SanofiCompletedType 2 Diabetes MellitusFrance, Russian Federation, United States, Argentina, Canada, Germany, South Africa, Italy, Netherlands, United Kingdom, Australia, Chile
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusRussian Federation, Romania, United States, India, Puerto Rico
-
Eli Lilly and CompanyCompletedLymphoma, Large Cell, DiffuseFrance, Germany, Russian Federation
-
Eli Lilly and CompanyCompletedFallopian Tube Neoplasms | Ovarian Cancer | Peritoneal NeoplasmSpain, Poland, Belgium, Russian Federation, Germany
-
SanofiTerminatedT-cell Type Acute Leukemia-Precursor | T-lymphoblastic Lymphoma/LeukaemiaHungary, United States, Finland, France, Italy, Lithuania, Russian Federation
-
Center Trials & TreatmentBioGene Pharmaceutical Inc.No longer availableGlioblastoma | Glioma of BrainBosnia and Herzegovina, Albania, Bulgaria, Croatia, Romania, Russian Federation, Serbia, Switzerland
-
AmgenEuropean EWALL study groupsCompletedAcute Lymphoblastic LeukemiaCzechia, Spain, France, Italy, Russian Federation, Germany, United Kingdom, Poland
-
European Society for Blood and Marrow TransplantationNovartisCompletedMyeloid Leukemia, ChronicGermany, Finland, Denmark, Poland, Saudi Arabia, United Kingdom, Israel, Hungary, Russian Federation
-
BayerCompletedCarcinoma, Renal Cell | Carcinoma, Renal Cell (Advanced)Poland, China, Slovakia, France, Germany, Indonesia, Korea, Republic of, Sweden, Philippines, Austria, Colombia, Czech Republic, Mexico, Russian Federation, Slovenia, Argentina, Greece, Netherlands
-
TakedaCompletedDiabetes MellitusRussian Federation
-
Janssen-Cilag International NVTerminatedMultiple MyelomaPoland, Turkey, Russian Federation, Hungary, Lithuania, Croatia, Germany
-
CelgeneCelgene CorporationCompletedCutaneous T-cell LymphomaUnited States, France, Germany, Poland, Russian Federation, United Kingdom
-
Astellas Pharma Europe B.V.CompletedAdvanced Prostate CarcinomaRussian Federation
-
AccentureCompletedRecurrent Platinum-resistant Ovarian CancerAustralia, Russian Federation, United Kingdom
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingNeurofibromatosis Type 1United States, Spain, Germany, Netherlands, Russian Federation, Italy, Japan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, China, India, Iran, Islamic Republic of, Korea, Republic of, Russian Federation, Poland, Japan, Italy, Canada, Greece
-
AstraZenecaCompletedType 2 DiabetesUnited States, Russian Federation, South Africa, Taiwan
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Poland, Romania, Russian Federation, Ukraine, India, Belgium, Mexico, Tunisia, Japan, Israel, Korea, Republic of
-
BiocadRecruitingAdvanced MelanomaRussian Federation, Belarus
-
AstraZenecaRecruiting
-
AmgenCompletedHyperlipidemia and Mixed DyslipidemiaUnited States, Canada, Denmark, France, Italy, Belgium, Czechia, Taiwan, Japan, Switzerland, Germany, United Kingdom, Korea, Republic of, Hong Kong, Netherlands, New Zealand, South Africa, Australia, Spain, Austria, Hungary, Russian... and more
-
SanofiTerminatedDiabetes Mellitus, Type 2United States, Poland, Romania, Russian Federation, Ukraine, Malaysia, Philippines, Taiwan, Mexico, Lithuania, Slovakia, Indonesia, Thailand
-
Ionis Pharmaceuticals, Inc.CompletedType 2 Diabetes MellitusPoland, Romania, Russian Federation
-
AB ScienceRecruitingIndolent Systemic MastocytosisFrance, Netherlands, Germany, United Kingdom, Russian Federation, Poland, Romania, Ukraine